Register studies of diabetes treatment arouse method discussions

2018-08-03T15:25:19+01:00September 25th, 2017|Categories: Endocrine, nutritional and metabolic diseases, Nordic Health Registers|

Randomized studies of SLGT-2 inhibitors and GLP-1 receptor agonists are now followed-up by register studies. And scientists are eagerly presenting real life data these years. This makes professor Anders Green to point out that scientists need to remember openness towards each others' methodological schools. Read the article from Medicinsk Tidsskrift here.